Sclafani Anthony P
Division of Facial Plastic Surgery, Department of Otolaryngology-Head & Neck Surgery, The New York Eye & Ear Infirmary, New York, NY 10003, USA.
Facial Plast Surg Clin North Am. 2007 May;15(2):251-4, viii. doi: 10.1016/j.fsc.2007.01.010.
Facial plastic surgery, by its nature, is a field that constantly is seeking new and innovative ways of treating patients. This innovation often involves novel techniques and tools. The US Food and Drug Administration is charged with regulating drugs and medical devices to ensure that the public is treated in safe and effective ways. It does not, however, regulate the practice of medicine. Physicians are able to use drugs and devices off-label but are required to follow certain guidelines. This article describes the physician's legal responsibilities and limitations in off-label drug or device use.
从本质上讲,面部整形外科学是一个不断寻求治疗患者新方法和创新方法的领域。这种创新通常涉及新技术和工具。美国食品药品监督管理局负责监管药品和医疗器械,以确保公众得到安全有效的治疗。然而,它并不监管医疗实践。医生可以超适应症使用药物和器械,但需要遵循某些指导原则。本文描述了医生在超适应症使用药物或器械方面的法律责任和限制。